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ABSTRACT
RNA–RNA recombination is an important pathway in
virus evolution and has been described for many
viruses. However, the factors driving recombination
or promoting the selection of recombinants are still
unclear. Here, we show that the small movement
protein (2b) was able to promote selection of RNA
1/2–RNA 3 recombinants within a chimeric virus
having RNAs 1 and 2 from cucumber mosaic
virus, and RNA 3 from the related tomato aspermy
virus, along with heterologous 2b genes. The source
of the 2b also determined the selection of the
acceptor RNA and the crossover site, as well as
affecting the rate of selection of the recombinant
RNAs. The nature of the RNA 3 also influenced the
selection of the recombinant RNAs. A 163-nt tandem
repeat in RNA 3 significantly affected the rate of
selection of the recombinant RNA, while a single
nucleotide within the repeat affected the crossover
site. The recombination occurred in a non-random
manner, involved no intermediates and probably
was generated via a copy-choice mechanism during
(+) strand RNA synthesis.
INTRODUCTION
RNA–RNA recombination is one of the most important
pathways in virus evolution. It was ﬁrst discovered in
the early 1960s in poliovirus (1,2) and has been docu-
mented in various genera of animal viruses, plant viruses
and bacterial viruses group. Studies conducted on viruses
during the last 40 years indicated that RNA–RNA
recombination could occur between RNAs of the same
or diﬀerent strains of one species (3,4), of diﬀerent
species (5) or between viral and host cellular RNAs
(6,7). RNA hairpins or mutations in a replicase domain
have been implicated to play an important role in
promoting RNA–RNA recombination (8–11). While
none of those studies demonstrated a role for non-
replicase proteins in viral RNA–RNA recombination
or selection of recombinants, recombination without
replication has been described (12,13).
RNA recombination has been studied extensively in the
plant virus genus Cucumovirus. Those studies have
involved two of the three recognized viral species in this
genus, Cucumber mosaic virus (CMV) and Tomato
aspermy virus (TAV). These viruses both contain a
single-stranded and positive-sense RNA genome divided
into three species designated RNAs 1, 2 and 3 (14,15).
RNA 1 encodes the 1a protein involved in virus
replication (16,17). RNA 2 encodes two proteins: the 2a,
also involved in virus replication (16,17) and the 2b
protein, involved in virus movement and the suppression
of RNA silencing (18–21). RNA 3 also encodes two
proteins, the 3a movement protein and the capsid protein,
both of which are also involved in virus movement
(22–24). Protein 2b is translated from a subgenomic
RNA of RNA 2, RNA 4A (25,26), while the capsid
protein is translated from a subgenomic RNA of RNA 3,
RNA 4 (27). The 30 terminal 305–310-nt non-translated
region (NTR) is nearly identical in each of the three
genomic RNAs of each virus and represents promoters for
( ) viral RNA synthesis during viral replication
(23,28,29). The location of most of the recombinants
described involving CMV and TAV is within these 30 NTR
sequences.
RNA–RNA recombination was ﬁrst described in
cucumoviruses isolated from tobacco plants after multiple
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containing RNAs 1 and 2 from CMV, and RNA 3 from
TAV (30). The progeny RNA 3 consisted mostly of TAV
RNA 3 but with the 30 terminal sequence from CMV
RNA 2. In addition, in an earlier passage, there was an
intermediate RNA 3 present containing a duplicated 21-nt
sequence at the crossover site (30). Subsequently, several
other cucumoviral recombinant RNAs were also discov-
ered in plants infected with a so-called quadripartite
hybrid virus having RNAs 2 and 3 from CMV, and RNAs
1 and 2 from TAV (31), with a mixture of wild-type
(wt) CMV and wt TAV (32,33), with mixed CMV isolates
(34–36), or within a single wt CMV (37). These
characterized recombinant RNAs had non-template-
derived nucleotides at the crossover site (31) and had
CMV sequences at one end of the crossover site and TAV
sequence at the other end (32) or had the same 30-terminal
NTR sequence for all three genomic RNAs (37). Some of
the recombinants had crossover sites localized within a
short region of high sequence similarity (32). Others were
predicted to occur in regions of high secondary structure
(33,34,38). TAV RNA 3 itself has a direct repeat of 163nt
(diﬀering by one nucleotide) in the 30 NTR, which is
not essential for infection (39) and in some cases, was
deleted during long-term incubation (40). While some of
the above studies examined recombinants formed in the
directly inoculated leaves and thus avoided detecting only
those replicable recombinants that might be selected
(32,33), other studies examined those recombinants
detected after slow selection (31,38) and found that some
recombinants could co-exist in the same plants (38).
However, what factors may have led to the selection of
particular recombinants has not previously been
examined.
Here we show that infection and passage of a chimeric
virus having RNAs 1 and 2 from CMV, with RNA 3 and
the 2b gene from TAV consistently resulted in the slow
selection of recombinant viruses. We demonstrate that the
2b gene plays a key role in promoting this selection.
MATERIALS AND METHODS
Plasmid construction
Plasmid cDNA clones, with transcription in planta
controlled by the cauliﬂower mosaic virus (CaMV) 35S
promoter and terminator, were used for plant inoculation.
A pGEX2T-based plasmid (Amersham Pharmacia
Biotech), pGEX-T2b, in which the gene encoding the
TAV 2b protein was fused with sequences encoding GST,
was used to express GST/TAV2b for RNA-binding assay.
Various plasmids used in this study are shown in Figure 1.
Plasmid cDNA clones C1 (previously named pQCD1),
C2 (pQCD2), C2T2B (pQCD2qt), C2T2BC2a (pQCD2qt1),
C2W2B (pQCD2qw), C3 (pQCD3), T1 (pCass1T1),
T2 (pCass1T2), T3 (pCass1T3) and T3163(A)
(pCass1T3163(A)) have all been previously described
(26,39,41–43). The other plasmid cDNA clones were
constructed as follows.
Plasmid cDNA clones C123,C 2 T2B23 and
T3163(A)23 were constructed through three steps: ﬁrst,
amplifying two fragments with appropriate primer
pairs (see Supplementary Table 1 for detailed primers),
then, digesting the ampliﬁed fragments with appropriate
restriction endonucleases; i.e. BstXI/BamHI for C123,
Asp718/BamHI for C2T2B23 and NheI/AvrII for
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Figure 1. Schematic representation of constructs used in this article.
The constructs regulated from the 35S promoter and 35S terminator
are indicated. The open reading frames encoding various cucumoviral
proteins on the constructs are shown. The 23nt of sequence identity
between all genomic RNAs is indicated by a short thick bar. The
tandem repeat of 163nt is indicated by an arrow. The crosshatch lines
represent the amino acid sequences diﬀerent from the native sequence
for either 2a or 2b.
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fragments into the appropriate sites created by digestion
with the same enzymes. Plasmid cDNA clones C13081–3390,
C2W2B2757–3065,T 3 163(A)141,T 3 1–2060,T 3 1–2223,
T31902–2386 and T32065–2386 were constructed via two
steps: ﬁrst amplifying appropriate fragments, and
then ligating these fragments into the pCass1 vector (43).
Plasmid cDNA clones C2W2BC2a and T3163(G) were
constructed with a QuickChange Site-Directed
Mutagenesis Kit (Stratagene) according to the manufac-
turer’s instruction. All the ampliﬁed fragments as well as
their joined regions in the plasmids were sequenced to
ensure whether they were correct.
Plant inoculation and RNA analyses
Two plant species, Nicotiana clevelandii and Nicotiana
glutinosa, were chosen for inoculation of the plasmid
cDNA clones. Unless speciﬁed otherwise, all inocula used
were a mixture of the three genomic cDNA clones
(corresponding to RNAs 1, 2 and 3), each at an equal
concentration of 10mg/10ml per plant. For each test,
at least ﬁve, four-leaf plants of each of the above two
species were inoculated mechanically after a 24-h dark
treatment. Each test was repeated at least once.
Total plant RNAs were extracted from infected plants
and analysed by northern blot hybridization as
described previously (26). The nylon membranes were
hybridized with a
32P-labelled transcript probe, comple-
mentary to the 30 terminal sequences of either TAV RNA
3 (nucleotide 2287–2386) or RNA 2 of the Q-strain of
CMV (Q-CMV; nucleotide 2871–3035). These two probes
would hybridize to all the genomic and subgenomic
RNAs of the corresponding viruses (39). An additional
probe complementary to nucleotide 1–1884 of TAV RNA
3 was speciﬁcally used to hybridize to the 50-terminal
region of TAV RNA 3.
RT-PCR and sequence determination
Viral particles and virion RNAs were puriﬁed according
to the method of Peden and Symons (44). Individual viral
RNAs were puriﬁed from the virion RNAs ﬁrst via an
agarose gel and then via a polyacrylamide gel (45).
The puriﬁed, single, viral RNAs were polyadenylated
with Escherichia coli poly(A) polymerase and then RT-
PCR was done using an oligo dT primer as described
previously (43). The ampliﬁed products were cloned into
the pBluescript SK
+ vector and sequenced from both
orientations.
The puriﬁed, single, recombinant RNAs, total RNAs
extracted from plants and total virion RNAs were also
reverse transcribed using primers T30 and C30, respec-
tively. T30 is complementary to the 30-terminal sequence of
TAV, while C30 is complementary to the 30-terminal
sequence of Q-CMV (see Supplementary Table 1 for
details). The synthesized ﬁrst-strand cDNAs from the
templates were ampliﬁed with diﬀerent pairs of primers,
C30/T3-1187, C30/C2-980, C30/C1-2032, T30/T3-1187,
T30/C2-980 and T30/C1-2032 (see Supplementary Table 1
for details), using the thermocycler program: 1min
at 948C, 1min at 528C and 2min at 728C for 30 cycles.
The ampliﬁed products were also cloned into the
pBluescript SK
+ vector and sequenced from both
orientations. At least ﬁve clones were sequenced from
each PCR product.
DNA sequencing was carried out using 4pmol of a
speciﬁc primer and 0.1mg of a cDNA clone. The sequence
reaction was incubated at 378C for 10min and then
analysed via a manual sequencing gel system. RNA
sequencing was carried out under the same conditions
as the DNA sequencing except that 10mg of the total plant
RNAs, 2mg of the virion RNAs or 1mg of a single RNA
were used as a template and that the sequence reaction
was incubated at 428C for 30min.
Purification of theTAV 2b proteinfrom Escherichia coli
The plasmid pGEX-T2b was constructed via two steps:
amplifying the PCR fragments ﬁrst and then cloning the
PCR fragments into appropriate vectors (as above).
PGEX-T2b was transformed into E. coli BL21 (DE3).
Protein expression was induced with 0.1mM IPTG
(isopropyl-b-D-thiogalactopyranoside). Puriﬁcation of
the protein was carried out using glutathione beads.
The cleavage of GST/TAV2b protein was carried out
using thrombin (Novagen) as recommended by the
manufacturer. The purity of the puriﬁed protein was
analysed by SDS–PAGE. The amount of puriﬁed protein
was measured using the Bio-Rad protein assay.
Preparation offull-length TAV RNA 3transcripts
DNA templates representing a full-length RNA 3 of TAV
and including T7 or T3 promoter were generated by PCR
using the infectious cDNA clone of TAV RNA 3 (T3) as a
template and primer pairs T30 and T7-TR3(+) (a primer
used for transcription of the sense RNA), or T50
(nucleotides 1–27 of TAV RNA 3) and T3-TR3( )
(a primer used for transcription of the anti-sense RNA;
see Supplementary Table 1 for the primer sequences).
Labelled transcripts from the DNA templates were
obtained using [
32P]-a-UTP and T7 or T3 DNA-depen-
dent RNA polymerase. The free nucleotides in the
transcription reaction were removed using P-30 micro
Bio-Spin columns (Bio-Rad), while the DNA templates
were removed by incubation with DNase I. The labelled
TAV RNA 3 transcripts were puriﬁed through a 4%
denaturing polyacrylamide gel and quantiﬁed by UV
spectrophotometry (Beckman).
Protein-RNA-binding assay
Three diﬀerent amounts (150, 300 and 450ng) of the TAV
2b protein puriﬁed from E. coli were each incubated
with 4ng of each of the [
32P]-labelled TAV RNA 3
transcripts in a binding buﬀer [50mM Tris–HCl (pH 8.2),
10mM MgCl2, 1mM EDTA, 10% glycerol, 200ng of
yeast tRNA (Sigma), and 2U of RNase inhibitor
(Promega)] at 258C for 30min (46). After incubation,
potential protein-RNA complexes were analysed via
electrophoresis on a 4% non-denaturing polyacrylamide
gel and detected by autoradiography.
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Identification and characterization of recombinant
RNAs inpassaged 2b-chimeric cucumovirus
Pseudorecombinant viruses formed between RNAs 1 and
2 of CMV and RNA 3 of TAV have been shown gradually
to yield stable, recombinant viruses after multiple passage
(30,31,38). However, the eﬀects of the various viral genes
on the selection of these recombinant viruses have not
been examined. Previously, using interspecies hybrid
viruses, we examined the roles of diﬀerent 2b genes on
virulence and virus accumulation and showed that while
the nature of the 2b gene inﬂuenced virulence, the RNA 3
(and therefore the two genes encoded by RNA 3; the 3a
movement protein and the capsid protein) did not (21,47).
Therefore, the hybrid viruses generated previously,
C1C2T2BC3 and C1C2T2BT3, where C indicates Q-CMV,
T indicates TAV, 1, 2 and 3 indicate RNAs 1, 2 and 3,
and the subscript T2B indicates that the 2b gene of
Q-CMV was replaced precisely with that of TAV
(Figure 1), were subjected to long-term, multiple passages
in N. glutinosa to determine whether the 2b gene had any
eﬀect on the selection of recombinant viruses. The
progeny viral RNAs were examined by northern blot
hybridization, with probes speciﬁc to the 30 terminal NTR
sequences of either the three Q-CMV RNAs or the three
TAV RNAs (Figure 1). This analysis indicated that in
the multiple passage plants TAV RNA 3 derived from
C1C2T2BT3 had recombined with CMV RNA, as the
progeny RNA 3 was detected by both the Q-CMV-speciﬁc
and TAV-speciﬁc probes (Figure 2A and B, compare lanes
9 and 20). By contrast, RNA 3 derived from the same
virus maintained for several weeks in the plasmid-
inoculated plants was not a recombinant RNA, as it
was only detected by the TAV-speciﬁc probe, but not by
the Q-CMV-speciﬁc probe (Figure 2A and B, compare
lanes 5 and 16). The speciﬁcity of the CMV-speciﬁc and
TAV-speciﬁc probes was demonstrated in that both
probes only detected their own speciﬁc viral RNAs
(Figure 2A and B, compare lanes 2 and 3, and lanes 13
and 14). The other RNAs of C1C2T2BT3 were still
detected by their speciﬁc probes in both the inoculated
plants and the multiple passage plants (Figure 2A and B).
To conﬁrm that RNA 3 was a recombinant, the RNA 3
derived from C1C2T2BT3 was gel-puriﬁed, reverse
transcribed with primers C30 and T30, respectively, and
then ampliﬁed with diﬀerent pairs of primers as described
in the Materials and Methods section. Only the primer
pair C30/T3-1187 was able to generate a speciﬁc RT-PCR
product (data not shown). T3-1187 corresponded to
sequences ending with nucleotide position 1187 of TAV
RNA 3, while C30 was complementary to the 30-terminal
sequence of Q-CMV. This indicates that the RNA 3 was
indeed a recombinant, having a TAV RNA 3 sequence in
the capsid protein region and a CMV RNA sequence at
the 30 terminus.
To determine the nature of the recombinant RNAs
derived from C1C2T2BT3, the recombinant RNAs
derived from this virus were puriﬁed from infected
plants, subjected to RT-PCR and the RT-PCR products
were then cloned into the pBluescript SK
+ vector
for sequencing. The sequencing results from ﬁve indepen-
dent clones showed that there was one type of RNA 3
recombinant derived from C1C2T2BT3, containing
2370nt, of which the 50 terminal 2060nt was derived
from the 50 terminal 2060nt of TAV RNA 3 (Figure 3A
right, open bar), while the 30 terminal 310nt was identical
to the 30 terminal 310nt of Q-CMV RNA 1 (Figure 3A
right, stippled bar). The crossover site on the TAV RNA 3
sequence was 7nt 50 of a homologous sequence of
23nt conserved in all three genomic RNAs, and 3nt
50 of this conserved 23nt sequence in the Q-CMV RNA 1
sequence.
The TAV RNA 3 sequence in the recombinant RNA 3
retained the ﬁrst repeat [in order of 50 to 30 on the (+)
sense strand] of two 163-nt tandem repeats (39), but
lacked the second one, which originally was present in
the TAV RNA 3 inoculum. The diﬀerence between the
two 163-nt repeats is an A at position 1966 in the ﬁrst
repeat, with a G at the corresponding position (2129)
in the second 163-nt repeat (Figure 3A left) (39).
The repeated sequences showed no diﬀerence in viral
pathogenicity when only one or the other was present (39).
The 30 terminal 310nt of the recombinant RNA 3 was not
only the same as the 310 terminal nucleotides of Q-CMV
RNA 1, but was also the same length as Q-CMV RNA 5.
Q-CMV RNA 5 is a mixture of subgenomic RNAs derived
from the 30 terminal NTR of RNAs 1, 2 and 3 [(48);
our unpublished data]. The level of RNA 5 has a strong
eﬀect on the severity of symptoms; the presence of more
RNA 5 in the plants results in less severe symptoms (our
unpublished data).
Repeated multiple passages of virus generated from the
plasmids comprising C1C2T2BT3 in 10N. glutinosa
plants or 10N. clevelandii plants resulted in the appear-
ance of the same recombinant RNA 3s with the same
border sequences among the sequenced clones. These
recombinant RNAs were not detected by northern blot
hybridization in the inoculated parental plants, even if the
plasmid-inoculum was increased 5-fold (50mg/10ml) or
decreased 20-fold (0.5mg/10ml), although the same
recombinant RNAs were detected again in the multiple
passage plants, when the initial inoculum concentration
was changed (data not shown).
The 2b gene determines the source ofthe
recombinant 3’terminus and crossover site
The observation that recombinant RNAs were detected
when the 2b gene of Q-CMV was substituted by that
of TAV (Figure 2A, lane 9), and not when the 2b gene of
Q-CMV was present in the interspeciﬁc hybrid virus
C1C2T3 (Figure 2A, lane 11) suggested that the 2b gene
has some role in the generation and/or selection of the
recombinant viruses. However, as the replacement of
the 2b sequence also changed the sequences encoding
the C-terminal 41 amino acids of the 2a protein, it cannot
be ruled out that the C-terminal 41 amino acids of the 2a
protein might play a role in the recombination and/or
selection. Therefore, to determine whether the C-terminal
41 amino acids of the 2a protein encoded by
the overlapping TAV 2a gene sequence had such a role,
1060 Nucleic Acids Research, 2008, Vol. 36, No. 4we introduced a stop codon upstream of the TAV 2b gene
in C2T2B to prevent the expression of the C-terminal
41 amino acids of the 2a protein (see C2T2BC2a in
Figure 1). Bioassay of C1C2T2BC2aT3 onto N. glutinosa
showed that the virus induced symptoms similar to those
induced by C1C2T2BT3 and northern blot hybridization
and RT-PCR analyses showed that recombinant RNA 3
still accumulated in the multiple passage plants, but not in
the inoculated plants (data not shown). Moreover,
the recombinant RNA 3 generated was the same as that
derived from C1C2T2BT3 (data not shown). Therefore,
the C-terminal 41 amino acids of the 2a protein encoded
by the TAV 2b sequence had no role in the recombination
and/or selection, indicating that the TAV 2b gene was
required for the recombination and/or selection.
That the 2b protein rather than the 2b RNA sequence
itself aﬀected the generation and/or selection of recombi-
nant RNA 3s could not be established conclusively, since
expression of the 2b gene was shown to be necessary
for the cell-to-cell movement, but not the replication of
the pseudorecombinant virus C1C2T3 (21). However, if
the 2b protein was actually involved in the recombination/
selection process, then at a minimum the 2b protein
should be capable of binding viral RNA. To determine
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Figure 2. Northern hybridization of accumulated viral RNAs in N. glutinosa. Total RNAs extracted from inoculated and passage N. glutinosa plants
were fractionated in 1.2% of agarose gel containing 1.1% formaldehyde, and then blotted to membranes. The hybridization of the membranes was
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Nucleic Acids Research, 2008, Vol. 36, No. 4 1061whether there was some interaction between TAV RNA
3 and the 2b protein, we performed an RNA–protein-
binding assay.
The TAV 2b protein (Figure 4B, lane 3) puriﬁed from
E. coli (Figure 4A) was able to bind to the T7-transcribed
(+) sense TAV RNA 3 (Figure 4C, lanes 2–4) as well as to
the T3-transcribed ( ) sense TAV RNA 3 (Figure 4D,
lane 3). The binding ability increased with an increasing
amount of the 2b protein (Figure 4C, compare lanes 1–4).
By contrast, comparable amounts of GST alone, which
was expressed and puriﬁed under the same conditions
as the TAV 2b protein (Figure 4B, lane 2), did not bind to
TAV RNA 3 (data not shown). This demonstrated
that RNA-binding activity was not due to a co-puriﬁed,
contaminating protein from E. coli. The signiﬁcance of the
more eﬃcient binding of the 2b protein to (+) versus ( )
sense RNA is unknown. The diﬀerent binding abilities
probably are due to diﬀerent sequences and/or structures
between RNA 3(+) and RNA 3( ). Since the 2b protein
was designated a movement protein (19) and was shown
to be required for the movement of pseudorecombinant
viruses containing C1C2T3 (21), the 2b protein probably
also binds to TAV RNA 3 in vivo.
Another approach to determine the role of the 2b
protein in the generation and/or selection of the recombi-
nant RNAs, was to use a diﬀerent 2b gene in the
heterologous interspeciﬁc hybrid virus. To this end,
we replaced the whole 2b gene of (the subgroup II
strain) Q-CMV with that from a subgroup IA strain of
CMV, WAII-CMV, generating the hybrid virus
C1C2W2BT3 (see C2W2B in Figure 1). The WAII-CMV
2b gene and the Q-CMV 2b gene are only 53.4% identical
at nucleotide level and the WAII-2b protein is 10 amino
acids longer than the Q-2b protein.
Co-inoculation of C2W2B, C1 and T3 onto N. glutinosa
plants followed by multiple passages at 1–2 weekly
intervals showed that C1C2W2BT3 induced symptoms as
severe as those induced by C1C2T2BT3, which were much
more severe than those induced by either of the parental
viruses (21). Northern blot hybridization showed
that RNA 3 derived from C1C2W2BT3 also had recom-
bined with a CMV sequence in the passage plants, but not
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Figure 3. Genome organization of C1C2T2BT3, C1C2W2BT3 and their derived recombinant viruses. The genomic RNAs or 2b genes of each virus are
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27 and 34, and lanes 29 and 36). This was supported
by RT-PCR analysis (data not shown). These data
strongly indicate that the 2b protein was required for
recombination and/or selection or the recombinant RNA
3s, and that this process was not TAV 2b protein-speciﬁc.
To determine the nature of the recombinant RNAs
derived from C1C2W2BT3, the recombinant RNA 3 was
subjected to RT-PCR, cloning and sequence analysis.
Surprisingly, the RNA 3 recombinants derived from
C1C2W2BT3 diﬀered from those derived from
C1C2T2BT3 or C1C2T2BC2aT3 in the following respects:
First, the recombinant RNA 3 derived from C1C2W2BT3
was 22nt longer than that derived from C1C2T2BT3
or C1C2T2BC2aT3 (2392 versus 2370). Second, the 30
terminal NTR of the recombinant RNA 3 derived from
C1C2W2BT3 contained a Q-CMV RNA 2 NTR sequence,
rather than the Q-CMV RNA 1 NTR sequence (compare
Figure 3A right and B right). Third, the crossover sites on
RNA 2 and on RNA 3 were diﬀerent in the recombinant
RNA 3 derived from C1C2W2BT3 versus either
C1C2T2BT3 or C1C2T2BC2aT3 (compare Figure 3A and
B). And fourth, the recombinant RNA 3 derived from
C1C2W2BT3 contained an imperfect repeat of 19nt near
the crossover site preceded by an A between the TAV
RNA 3 sequence and the 30 CMV RNA sequence
(Figure 3B). Moreover, the recombinant RNA 3 derived
from C1C2W2BT3 also was missing the second 163-nt
repeat. These similarities on one hand and diﬀerences on
the other suggested that the recombinant RNA 3s derived
from C1C2T2BT3 and C1C2T2BC2aT3 versus C1C2W2BT3
might be generated using diﬀerent templates, but occurred
via a similar mechanism. Taken together, the above
results indicate that the 2b protein determined either the
RNA species participating in the recombination and
the crossover site, or selected for particular recombinant
RNAs generated at random that have the above
characteristics.
The 2b proteinand a163-nt tandemrepeat on RNA 3
bothaffectthe rate of recombinant selection while a
singlenucleotide within the repeat determines the
crossover site on RNA 3
Both the TAV 2b protein and WAII-CMV 2b protein
were able to promote the recombination and/or selection
of RNA 3 in the passage plants, but not in the inoculated
plants. To determine when the recombinant RNA 3s
could ﬁrst be detected, a time-course experiment was done
involving three viruses: C1C2T2BT3, C1C2T2BC2aT3 and
C1C2W2BT3. The appropriate plasmid combinations
were inoculated onto 10 N. glutinosa plants and sap was
then passaged onto healthy N. glutinosa plants for 10
passages, at 6-day intervals. The inoculated leaves of the
passage plants were detached 3 days after inoculation,
total RNAs were extracted and the RNAs were analysed
by northern blot hybridization. These analyses showed
that the recombinant RNAs were only detected from
the fourth passage and onwards in plants infected with
C1C2T2BT3 or C1C2T2BC2aT3, or from the sixth passage
and onwards in plants infected with C1C2W2BT3
(Supplementary Figure 1A, data not shown). These results
indicated that selection of the recombinant RNA 3s is a
slow process and therefore it seems more likely that the
2b proteins were selecting for speciﬁc recombinants, rather
than being involved in the generation of the recombinant
RNA 3s. This is also consistent with the diﬀerent
subcellular localization of the replication proteins and
the 2b protein (49–51) and the lack of detectable
interaction of the replicase proteins with the 2b protein
(52). In addition, virus containing the TAV 2b protein
showed selection of the recombinant RNA 3s two
passages earlier than did virus containing the WAII-
CMV 2b protein. Therefore, it seems likely that the source
of the 2b protein also aﬀected the rate of selection.
To examine the role of the two 163-nt repeats in the
recombination and/or selection, we deleted each repeat
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Figure 4. TAV 2b protein expression, puriﬁcation and RNA 3 binding.
(A) The TAV 2b protein fused with GST and transformed into
the bacteria strain BL21 (DE3) was analysed by SDS–PAGE.
Total bacterial lysate after the induction of protein expression
(lane 2; tp) was passaged through glutathione beads to purify the
GST-2b fusion protein (lane 3; pp). Molecular mass markers (M) are
shown in lane 1. (B) Puriﬁed GST-2b fusion protein (lane 1) was
cleaved using thrombin and the resulting products, GST (lane 2) and 2b
proteins (lane 3), were gel-puriﬁed. GST protein was treated with
thrombin (lane 2). The gels in A and B were stained with Coomassie
Blue. (C and D) Autoradiograms of gel retardation electrophoresis
assays of the 2b protein binding to RNA 3. Increasing amounts of
the 2b protein were incubated in the binding buﬀer as with 4ng of
either
32P-labelled TAV RNA 3 (+) transcript (C) or
32P-labelled TAV
RNA 3( ) transcript (D). The samples were electrophoresed in 4%
non-denaturing polyacrylamide gels. The amounts of the 2b protein,
the position of free RNA 3 (f) and the position of retarded RNA 3 (r)
are indicated.
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mutants were designated C1C2T2BT3163(A) and
C1C2T2BT3163(G) (Figure 1), where the subscripts
163(A) and 163(G) represent the ﬁrst 163-nt repeat
deletion and the second 163-nt repeat deletion, respec-
tively. Bioassay of C1C2T2BT3163(A) and
C1C2T2BT3163(G) onto N. glutinosa plants showed that
both deletion mutants induced similar symptoms to those
induced by C1C2T2BT3 (data not shown). Northern blot
hybridization analysis showed that neither deletion
aﬀected the presence of recombinant RNA 3s in the
multiple passage plants (Figure 2A, lanes 8 and 19, data
not shown). However, both deletion mutants yielded
recombinant RNA 3s in both the inoculated plants
and the passage plants (Figure 2A and B, compare lanes
4 and 15, and lanes 8 and 19, data not shown).
Repeated inoculation and northern blot hybridization
analysis gave the same results as earlier. This suggests
that the two 163-nt repeats aﬀected the rate of the
recombination and/or selection of recombinants.
To conﬁrm the role of the two 163-nt repeats in
aﬀecting the rate of recombination and/or selection, we
generated two other deletion mutants, C1C2W2BT3163(A)
and C1C2W2BT3163(G). Bioassay of C1C2W2BT3163(A)
and C1C2W2BT3163(G) showed that these two deletion
mutants also induced symptoms similar to those induced
by C1C2W2BT3 (data not shown). Northern blot hybridi-
zation analysis showed that the deletions also resulted
in the generation of the recombinant RNA 3s in both
the inoculated and passage plants (Figure 2C and D,
compare lanes 26 and 33, and lanes 28 and 35, data
not shown). These results showed that the two 163-nt
repeats indeed aﬀected the rate of the recombination
and/or selection.
To determine the nature of the recombinant RNA
3s derived from the 163-nt repeat-deletion mutants,
we again puriﬁed the recombinant RNA 3s of
C1C2T2BT3163(A),C 1 C 2 W2BT3163(A),C 1 C 2 T2B
T3163(G) and C1C2W2BT3163(G), used RT-PCR to
amplify the recombinant sequences, cloned the RT-PCR
products and sequenced them. The sequences of the
recombinant RNA 3 derived from C1C2T2BT3163(A)
contained the 50-proximal 2082nt from TAV RNA 3
and the 30 proximal 310-nt 30 NTR of CMV RNA 1
(Figure 5A). The CMV RNA 1 NTR sequence was
identical to that present in the recombinant RNA 3
derived from C1C2T2BT3. However, the TAV RNA 3
sequence was 22nt longer than that of the recombinant
RNA 3 derived from C1C2T2BT3 (compare Figures 3A
and 5A), suggesting that the ﬁrst 163-nt repeat might
have a role in determining the crossover site on one of
the participating RNAs, despite not aﬀecting the cross-
over site on the other participating RNA. By contrast,
the sequence of the recombinant RNA 3 derived from
C1C2T2BT3163(G) was exactly the same as that derived
from C1C2T2BT3 (compare Figures 3A and 5B), indicat-
ing that the second 163-nt repeat had no role in
determining the crossover sites on either RNA.
The recombinant RNA 3 derived from C1C2W2B
T3163(A) consisted of the 50 proximal 2082nt from
TAV RNA 3 and the 30 proximal 309-nt 30 NTR of
CMV RNA 2 (Figure 5C). Although the 2082nt sequence
from TAV RNA 3 was exactly the same as that in the
recombinant RNA 3 derived from C1C2T2BT3163(A),
it was 18nt longer than the one seen in the recombinant
RNA 3 derived from C1C2W2BT3 (compare Figures 3B
and 5C). This result supports the conclusion that the
ﬁrst 163-nt repeat might indeed aﬀect the left border of
the crossover site. The CMV RNA 2 sequence present
in the recombinant RNA 3 derived from C1C2W2B
T3163(A) was 19nt shorter than the CMV RNA 2 present
in the recombinant RNA 3 derived from C1C2W2BT3
(due to the absence of the additional A and the ﬁrst 19-nt
repeat shown in Figure 3B, but with an additional U
residue, nucleotide 2757), suggesting that the ﬁrst 163-nt
repeat might also aﬀect the right border of the crossover
site. In the recombinant RNA 3 derived from
C1C2W2BT3163(G), the sequence was exactly the same as
that of the recombinant RNA 3 derived from C1C2W2BT3
(compare Figures 3B and 5D), conﬁrming that the second
163-nt repeat had no role in determining the position of
the crossover sites on either RNA. Since only one
nucleotide diﬀered in the two 163-nt repeats (A versus
G), the above results indicate that the position of the
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Figure 5. Genome organization of C1C2T2BT3163(A),
C1C2T2BT3163(G), C1C2W2BT3163(A), C1C2W2BT3163(G) and their
derived recombinant viruses. The origin of the 30 NTR of each RNA
3 is diﬀerentiated by ﬁll patterns (stippled for RNA 1 and crosshatched
for RNA 2). The short black bars on the RNAs represent the 23nt of
sequence identity. The arrows on RNA 3 represent one of the tandem
repeats (A or G). The junction site of each RNA 3 recombinant is
indicated. The nucleotide sequence in the junction site of the RNA 3
recombinant derived from C1C2W2BT3163(G) is indicated. The
sequence in italics is from TAV RNA 3. The sequences underlined
represent the imperfect 19-nt repeats. The single nucleotide diﬀerence in
the repeats is indicated by an asterisk.
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diﬀerence within each repeat.
Recombinant RNA 3s involve no detectable
intermediates andare precisely generated
To determine whether the recombinant RNA 3s derived
from C1C2W2BT3 or C1C2W2BT3163(G), both of which
contained a 19-nt repeat sequence, might represent an
intermediate, buﬀered extracts from plants infected by
viruses containing these recombinant RNA 3s were
passaged onto ﬁve healthy plants for more than
20 passages done at 1-week intervals. RT-PCR and
sequence analyses of the recombinant RNA 3s from the
passage plants showed no sequence diﬀerence from
the original recombinant RNA 3s described above,
indicating that the 19-nt repeat was still present in the
same position as before (data not shown). These results
indicate that recombinant RNA 3 derived from
C1C2W2BT3 or C1C2W2BT3163(G) containing the 19-nt
repeat was not an intermediate, but the stable recombina-
tion end-product.
To examine how soon after infection this 19-nt repeat
was generated and whether there was an intermediate
generated before this 19-nt repeat appeared, a time-
course experiment was done, in which two viruses,
C1C2T2BT3163(G) and C1C2W2BT3163(G), were inocu-
lated onto N. clevelandii. Nicotiana clevelandii was chosen
as the host because the symptoms are more readily seen on
this host than on N. glutinosa (unpublished data) and
C1C2T2BT3163(G) and C1C2W2BT3163(G) were chosen
because both viruses showed more rapid appearance of
recombinant RNA 3 (see above). Moreover, the recombi-
nant progeny virus of C1C2W2BT3163(G) contained the
19-nt repeat, which could be used as a marker to
determine whether there was an intermediate before this
ﬁnal product. After inoculation of each virus to 200
plants, leaves were detached from groups of ﬁve inocu-
lated plants at 1-day intervals for up to 40 days. Northern
blot hybridization of the total RNAs extracted from the
detached leaves showed that recombinant RNA 3s derived
from any of the above viruses did not accumulate to a
detectable level before day 35; the earliest time when a
recombinant RNA 3 could be detected by northern blot
hybridization was at day 35 in the C1C2T2BT3163(G)-
infected plants (Supplementary Figure 1B). The recombi-
nant RNA 3 derived from C1C2W2BT3163(G) was not
detected during the whole time-course of the experiment
(data not shown). However, by using RT-PCR with the
primer pair C30/T3-1187, the recombinant RNA 3 derived
from C1C2T2BT3163(G) was detected as early as day 22
(Figure 6 upper panel), while the RNA 3 recombinant
derived from C1C2W2BT3163(G) could be detected at day
35 (data not shown). These results also conﬁrmed that the
TAV 2b protein promoted the recombination/selection
faster than the WAII-CMV 2b protein.
To characterize the RT-PCR products further,
Southern blot hybridization was done using CMV-speciﬁc
and TAV-speciﬁc probes. All the RT-PCR products on
the gel were the same size (Figure 6 middle and lower
panels) and the size was also the same as for the RT-PCR
products obtained from the passage plants (data not
shown). In addition, all the RT-PCR products were able
to hybridize with both the Q-CMV-speciﬁc probe and the
TAV-speciﬁc probe (Figure 6 middle and lower panels).
Sequencing of these RT-PCR products showed that the
RT-PCR products from the C1C2T2BT3163(G)-inoculated
plants contained 874nt derived from TAV RNA 3 (up to
nucleotide 2060 of TAV RNA 3) and 310nt from CMV
RNA 1. This sequence was exactly the same as that
derived from the same virus in the passage plants and
also the same sequence as that derived from C1C2T2BT3,
either in the inoculated plants or in the passage plants
(Figures 3A and 5B; data not shown). All of the RT-PCR
products derived from C1C2W2BT3163(G) also were
exactly the same in sequence, having 878nt from TAV
RNA 3 and 326nt from CMV RNA 2 including the 19-nt
repeat (Figure 5D; data not shown). The sequence of the
RT-PCR products also were the same as those from
the passage plants, or those derived from C1C2W2BT3 in
both the inoculated plants and passage plants (Figure 3B;
data not shown). These results indicate that the
recombinant RNA 3s accumulating in the infected
plants did not contain a detectable intermediate, and
that the crossover sites on both donor and acceptor RNAs
occurred at the same position.
The conserved23-nt sequence and the3’ NTR
ofRNA 3are critical forinfection
The conserved 23-nt sequence at the beginning of the 30
NTR has been implicated in the recombination and
nucleotides 1–20 of the 23-nt sequence also have been
C
M
V
23 22 24 25 26 M
day after inoculation
CMV 3′-specific probe
TAV 5′-specific probe
EB stain 1050bp
21
Figure 6. Agarose gel and Southern hybridization of RT-PCR products
from C1C2T2BT3163(G). RT-PCR was done using primer pair C30/T3-
1187 and total RNAs extracted from the plants at day 22–26 after
inoculation with C1C2T2BT3163(G). Top row: The RT-PCR products
were analysed on a 1% agarose gel and stained with ethidium bromide
(EB). The sizes of the products are indicated. M in the left lane
indicates the DNA ladder, while CMV in the right lane is used as a
negative control showing no RT-PCR product is obtained from the
plants infected with Q-CMV alone. Middle row: The RT-PCR products
on the gel were blotted to membranes and hybridized with the Q-CMV-
speciﬁc probe. Bottom row: The same RT-PCR products were blotted
and hybridized with the TAV-speciﬁc probe.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1065suggested to be an internal subgenomic promoter site
(33,38). This sequence also was always near the crossover
sites in the recombinant RNA 3s observed here, and the
19-nt imperfect repeat also comes from this sequence.
Therefore, we examined the requirement for this sequence
in infection. Three deletion mutants were constructed:
C123,C 2 T2B23 and T3163(A)23, where the conserved
23-nt sequence was deleted from each of C1, C2T2B and
T3163(A), respectively. Co-inoculation of each deletion
mutant in the combinations C123 with C2T2B23 and
T3163(A)23,C 1 23 with C2T2B and T3163(A), C1 with
C2T2B23 and T3163(A), or C1 with C2T2B and
T3163(A)23, onto N. glutinosa and N. clevelandii plants,
showed that none of these combinations was able to infect
the plants (Table 1). However, when either C123 was
combined with C2 and C3, or T3163(A)23 was combined
with T1 and T2, the mixtures were infectious (Table 1),
indicating that the presence of this 23-nt sequence is
essential for infection of the pseudorecombinant viruses,
but not the parental viruses. Since the pseudorecombinant
viruses containing the 23-nt sequence were viable
without detectable recombination for some time
(Figure 2), these results indicate that the 23-nt sequence
is not essential for replication of the pseudorecombinant
virus, but may be essential for maintaining infection
of the pseudorecombinant viruses through the plants,
just as the 2b protein was required for this task, but not
for the maintenance of infection of the parental viruses
(19,21).
The above results showed that the CMV sequence in
the recombinant RNA 3 was similar or identical to the
CMV RNA 5 sequence. Correspondingly, the TAV RNA
3 sequence in the same recombinant RNA 3s lacked
the second 163-nt repeat and the rest of the 30 NTR (which
together corresponds to the TAV RNA 5 sequence).
To determine whether CMV RNA 5 itself or the 30 NTR
of CMV RNAs 1 and/or 2 could be used as a template
for the synthesis of the recombinant RNA 3, we prepared
the appropriate templates that would be expressed
transiently in inoculated plants and assessed these for
the presence of recombinant virus. In the templates, we
deleted 326nt from the 30 NTR of T3 to make T31–2060,
and deleted the ﬁrst 163-nt repeat plus 141nt from the 30
NTR of T3 to make T3163(A)141 (Figure 1). These two
deletions had the same length of the TAV RNA 3 sequence
as in the recombinant RNAs. In addition, we also
made four RNA 5-like cDNA clones, C13081–3390,
C2W2B2757–3065,T 3 1902–2386 and T32065–2386. The former
two were based on the CMV RNA 1 and C2W2B sequences
in the recombinant viruses, respectively, while the latter
two were based on the sequence of TAV RNAs 3B and 5,
respectively (39). All of these clones were placed into
the pCass1 vector, under transcriptional control of the
CaMV 35S RNA promoter and terminator sequences.
The infectivity results of the various plasmid mixtures
tested on N. glutinosa and N. clevelandii plants are shown
in Table 1. The combinations C1, C2T2B,T 3 1–2060, versus
C1, C2T2B,T 3 163(A)141, versus C1, C2W2B,T 3 163(A)141
all showed no infectivity. The addition of the plasmids
expressing the 30-terminal NTRs C13081–3390,
C2W2B2757–3065,T 3 1902–2386 or T32065–2386 into each mix-
ture did not result in infectivity (Table 1). These results
indicate that the sequences containing the 30 NTR are
essential for the viral infection and could not be separated
functionally from the rest of the TAV RNA 3 sequence.
In addition, the results also indicate that the recombina-
tion observed in other experiments did not occur
during the synthesis of ( ) sense RNA from (+) sense
templates, since there was no repair of the 30 NTR from
synthesis initiated on either genomic RNAs 1 or 2, or
subgenomic RNAs 3B or 5 (Table 1) and template
switching to TAV RNA 3 lacking the 30 NTR. Such
repair recombination is common among tombusviruses
(8,53) and occurs with the related brome mosaic virus
(54–56). Therefore, an alternative explanation is that
the recombination occurred during (+) sense RNA
synthesis on the ( ) sense RNA templates, with recombi-
nation occurring as a result of template switching of
the viral replicase from the donor (TAV RNA 3) strand to
the acceptor (CMV RNA) strand.
A modelfor thegeneration of thevarious
recombination products
Based on putative secondary structures for the 30 NTRs
of CMV and TAV, models have been proposed to account
for the generation of some of the other recombination
products previously observed to occur between CMV and
TAV (33,38). These models are based on template
switching of the viral replicase on a stem-loop structure
present in the ( ) RNA 3 (L1/L2 in Figure 7) that may
be the promoter for the synthesis of subgenomic RNAs 3B
and 5 (33,38). Similar structures can be used to explain
the various recombinant products obtained here and the
eﬀect of the 163-nt repeats and the single G to A
substitution on the recombination event.
This model assumes that intramolecular recombination
is a more frequent event than intermolecular
Table 1. Infectivity of plasmid inocula
Inoculum N. clevelandii N. glutinosa
C123C2T2BT3163(A)   
C123C2C3 + +
C1C2T2B23T3163(A)   
C1C2T2B23C3   
C1C2T2BT3163(A)23   
T1T2T3163(A)23 ++
C1C2T2BT3163(A)141   
C1C2W2BT3163(A)141   
T1T2T3163(A)141   
C1C2T2BT31–2060   
T1T2T31–2060   
C1C2T2BT3163(A)141C13081–3390   
C1C2T2BT3163(A)141C2W2B2757–3065   
C1C2T2BT3163(A)141T31902–2386   
C1C2T2BT3163(A)141T32065–2386   
C1C2T2BT31–2060C13081–3390   
C1C2T2BT31–2060C2W2B2757–3065   
C1C2T2BT31–2060T31902–2386   
C1C2T2BT31–2060T32065–2386   
‘+’ indicates infection, while ‘ ’ indicates no infection. The nature of
the plasmid constructs is described in Figure 1.
1066 Nucleic Acids Research, 2008, Vol. 36, No. 4Figure 7. Proposed secondary structure of RNA 3 sequences complementary to the 30 NTR of TAV RNA 3. The residues are numbered according to
the corresponding (+) RNA 3, with nucleotide 1902 (underlined) as the position complementary to the 50 ﬁrst nucleotide of TAV RNA 3B. Stem-
loops are labelled starting from the 50 end of the ( ) TAV RNA 3, as complementary to those stem-loops of the 30 end of (+) TAV RNA 3 (A–H)
described previously (64). Those stem-loops present in the ﬁrst 163-nt repeat (L2-H2) are shown in (A), while those present in the second 163-nt
repeat (L1-H1) and loop G are shown in (B), with the remaining 50 proximal stem-loops and non-base-paired sequences of ( ) TAV RNA 3 shown
in (C). The sites of recombination observed here are indicated by an asterisk (nucleotide 2060), a dagger (nucleotide 2064) or an arrow (nucleotide
2245) in (B and C). The site of recombination described in Ref. (30) is at position 1973 and is indicated by an arrow in (A). The single nucleotide
diﬀerence (nucleotides 1966 and 2129) between the ﬁrst and second 163-nt repeat is shown in blue and is underlined. A possible pseudoknot can be
formed between the three As at the top of stem-loop G and the three Us (shown in blue) in the non-base-paired region between stem-loops K2 and
J2 in the ﬁrst 163-nt repeat, but not with the corresponding CUU sequence shown in the second 163-nt repeat. [Note: Neither stem-loops B nor F are
indicated, since loop B did not contain a stem in (+) TAV RNA 3 (64) and small stem-loop F was composed of several non-canonical G–U base
pairs in (+) TAV RNA 3 (54) and is not present in ( ) TAV RNA 3]. The G values (kcal/mol) for the various stem-loops are A= 11.5,
C= 7.8, D= 8.4, E= 6.8, G= 1.3, H= 2.9, I= 4.8, J= 3.8, K= 2.7, L1= 6.9 and L2= 5.7, as calculated from Ref. (65).
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progeny with deletion of one of the 163-nt repeats is more
likely to occur than recombination between TAV RNA 3
and another viral genomic RNA. That is, if one repeat is
missing, then only intermolecular recombination can
occur, which may explain why the recombinants were
seen to accumulate more rapidly in the plants directly
inoculated with virus containing only one repeat
(Figure 2). On the other hand, loss of a repeat was not
a prerequisite for intermolecular recombination, since
intramolecular recombination would involve loss of the
ﬁrst repeat [163(A)], while the recombinants formed from
the full-length T3 all retained the ﬁrst repeat. Intramole-
cular recombination would be expected to occur during
(+) TAV RNA 3 synthesis, if the polymerase jumped
from the beginning of the ﬁrst repeat in stem-loop L2
(Figure 7A) to the beginning of the second repeat in stem-
loop L1 (Figure 7B). These sequences also contain the
putative RNA 5 subgenomic promoter sequence (33,38)
that would facilitate this recombination and those
described previously that involved this ‘hot spot’
for intermolecular recombination between TAV and
CMV (33,38). The presence of another stem-loop structure
(K1/K2 in Figure 7) immediately adjacent to the
putative subgenomic promoter may slow the polymerase
down suﬃciently to stutter and in some cases switch
templates. In the case of the ﬁrst TAV-CMV RNA 3
recombinant described (30), this occurred just before
another stem-loop structure in the ﬁrst repeat (J2 in
Figure 7A; see arrow), but in that instance, the polymerase
jumped to the putative RNA 5 subgenomic promoter of
( ) CMV RNA 2, leading to an initial recombinant
that had a duplication of the two, putative subgenomic
RNA promoters, which then led to a second recombina-
tion event, with the intervening TAV RNA 3 sequences
deleted, giving the ﬁnal, stable recombinant RNA 3
described (30).
The full-length TAV RNA 3, as well as the T3163(G)
variant gave rise to similar recombination products,
with the exact switchover position on the donor RNA of
the recombinant determined by the 2b gene present
(T2B versus W2B), while the switchover position on the
receptor RNA is the beginning of the RNA 5 sequence in
either CMV RNAs 1 or 2, again determined by the
speciﬁc 2b gene present. In the case of C1C2T2BT3 and
C1C2T2BT3163(G), the recombination occurred immedi-
ately after nucleotide 2060. For C1C2T2BT3, switchover
would have had to occur at the base of stem-loop L1
(Figure 7B), while for C1C2T2BT3163(G), switchover
would have had to occur within stem-loop G (Figure 7B
and C), since the sequences comprising stem-loop L1
(plus stem-loops K1 to H1) would not exist in
C1C2T2BT3163(G). Since stem-loops L1 and G are quite
diﬀerent in most of their sequence and structure, as well
as stability (G=–1.3kcal/mol for stem-loop G and
 6.9kcal/mol for stem-loop L1), it seems likely that the
common structures preceding these stem-loops (J2-I2-H2
versus J1-I1-H1; G= 3.8,  4.8 and  2.9kcal/mol,
for each stem-loop structure) may have slowed the
polymerase suﬃciently to allow it to pause at nucleotide
2060, in either stem-loop L1 or G (Figure 7B).
In the case of C1C2W2BT3163(G), switchover occurred
following nucleotide 2064 in stem-loop G, but did not
immediately proceed to the ( ) CMV RNA 2 as the
receptor RNA. Rather, the polymerase jumped back to
the subgenomic promoter stem-loop (L2) and copied this
through the A residue in the gap between stem-loops L2
and K2 (Figure 7A), before pausing and jumping to
the same subgenomic promoter sequence on ( ) CMV
RNA 2. The small diﬀerence in G between the 6bp
stem-loop K2 in ( ) TAV RNA 3 (G= 2.7kcal/mol)
and a weaker 3bp stem-loop (K0) structure adjacent
to the subgenomic promoter in ( ) CMV RNA 2
(G= 2.1kcal/mol) may be suﬃcient to prevent the
polymerase from pausing at the base of stem-loop K0 in
( ) CMV RNA 2. This explains the duplication of the
19nt seen in Figure 5D, following the A residue (from
copying the ﬁrst nucleotide, U-1902 of the RNA 5/3B
promoter). In the case of C1C2W2BT3, the same recombi-
nant progeny RNA 3 is seen, but it must have been
generated from a diﬀerent starting point, since the second
repeat is present in the template but missing in the
recombinant progeny RNA 3. Here, template switching
occurred either immediately after nucleotide 2084 (the A
residue in the gap between stem-loops L1 and K1),
again leading to a partially duplicated subgenomic
promoter with the 19nt repeat, or it occurred at nucleotide
2064, in the lower region of stem-loop L1 (Figure 7B),
and then proceeded as described above for
C1C2W2BT3163(G).
In contrast to C1C2T2BT3163(G), C1C2T2BT3163(A)
and C1C2W2BT3163(A) underwent recombination 22nt
further along the TAV RNA 3 molecule after nucleotide
2245, adjacent to stem-loop E (in Figure 7C), regardless
of the nature of the 2b protein. Therefore, while the
nature of the receptor RNA and the apparently slow
selection of the recombinants (Figures 2 and 6) were
determined by the 2b gene, the generation of recombinants
at position 2245 was determined by the absence of the ﬁrst
repeat. Since the ﬁrst and second repeats diﬀer by only one
nucleotide (underlined blue letters in Figure 7A and B,
at positions 1966 and 2129), we propose that there must be
a diﬀerence in structure between the virus containing
only one repeat, when this is the second repeat versus
the ﬁrst repeat, and that this diﬀerence in structure aﬀects
pausing by the polymerase, leading to switchover
to another template. This diﬀerence could be the presence
(or absence) of a weak pseudoknot structure formed
between the three A residues in the loop of stem-loop G
and the three U residues in the non–base-paired region
between stem-loops K2 and J2 (see blue letters in
Figures 7). This pseudoknot would not be stable in
T3163(A), since it would only contain two A:U base pairs.
This weak pseudoknot structure may be suﬃcient to aﬀect
pausing by the polymerase in the T3163(G) variant, if it
can re-form after the polymerase has gone through it the
ﬁrst time and then transcribed through the various,
following stem-loop structures (stem-loops J, I and H in
Figure 7), leading to template switching in stem-loop G.
However, as this pseudoknot is absent in T3163(A),
the polymerase would continue through stem-loop G
until it pauses at the base of stem-loop E (Figure 7C;
1068 Nucleic Acids Research, 2008, Vol. 36, No. 4G= 6.8kcal/mol), before switching to the receptor
RNA.
It would seem likely that the polymerase is as equally
able to use RNA 1 as RNA 2 for the receptor RNA, since
the polymerase is essentially the same in all cases, and the
presence or absence of the 2a protein C-terminal
sequences (where the recombinant polymerases showed
some diﬀerences in sequence) did not aﬀect the nature
of the recombinant RNAs. However, since only one type
of recombinant progeny was observed in each case, this
demonstrates that there must have been selection for a
particular progeny RNA, which depended on the source
of the 2b gene and its encoded protein.
How could the nature of the 2b protein aﬀect the
selection of recombinant RNAs? It is conceivable that
the selection of recombinant RNAs is a manifestation of
the RNA silencing suppression-related functions of the 2b
proteins, since some of these also vary between strains of
CMV (57,58). However, based on the spatial separation
of the 2b protein from the replication machinery within
the cell (49–51), it is diﬃcult to envision how diﬀerent 2b
proteins provide the selection observed through their
RNA silencing suppressor functions. In the case of the
tombusvirus cucumber necrosis virus, inhibition of
expression of the 20-kDa protein now known to be the
RNA silencing suppressor of this virus, led to the rapid
appearance of defective-interfering RNAs (59). Thus,
in that, the absence of the silencing suppressor led to
enhanced generation or selection of recombinant RNAs,
while in the case of CMV, the source of the 2b protein
determined the nature of the recombinant RNAs selected
and pseudorecombinant viruses could not be selected in
its absence (21). Moreover, in the case of inﬂuenza virus,
where the NS1 gene encodes an RNA silencing suppressor
(60), mutation in a diﬀerent gene (NS2) led to the rapid
appearance of defective interfering particles (61).
At the time it was thought that the inﬂuenza NS2 protein
might be involved in replication. In fact, the NS2
protein is involved in selecting ribonucleoprotein com-
plexes for transport from the nucleus to the cytoplasm and
is now called the nuclear export protein (62).
Based on previous observations that the 2b protein is
also a movement protein (19,63), that the presence of the
2b protein was necessary for the cell-to-cell movement
of pseudorecombinants viruses (21), and that the 2b
protein is a viral RNA-binding protein (Figure 4), it seems
likely that the 2b binds to and selects speciﬁc recombinant
viral RNAs for cell-to-cell movement. The diﬀerent forms
of recombinant RNAs generated may have diﬀerent
aﬃnities for the various 2b proteins, leading to selection
of one recombinant form over another by a particular 2b
protein, which leads eventually to selection of the
recombinant RNA over the parental RNA. Since selection
to reach detectable levels was only observed after several
weeks, the recombinant viral RNAs do not appear to be
under strong selection pressure, although there is clearly
a gradual selection for the recombinant RNAs over
the parental RNA 3. This was seen in the slow appearance
of the recombinant RNAs in both sets of time course
experiments (Figure 6 and Supplementary Figure 1).
The rate of selection could be tested further by direct
competition experiments. The Q-CMV 2b protein did
not select for any recombinants, while the TAV and
WAII-CMV 2b proteins selected for diﬀerent recombi-
nants, possibly reﬂecting diﬀerences in their RNA-binding
properties. It would also be interesting to determine
whether various 2b mutants would show diﬀerences in
their selection of diﬀerent recombinants.
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